NASDAQ:INVO INVO Bioscience (INVO) Stock Price, News & Analysis → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free INVO Stock Alerts $0.93 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$0.90▼$0.9650-Day Range$0.77▼$1.8252-Week Range$0.50▼$8.60Volume107,506 shsAverage Volume2.74 million shsMarket Capitalization$2.55 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get INVO Bioscience alerts: Email Address Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. About INVO Bioscience Stock (NASDAQ:INVO)INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.Read More INVO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INVO Stock News HeadlinesMay 7, 2024 | americanbankingnews.comINVO Bioscience (NASDAQ:INVO) Stock Price Down 7%April 24, 2024 | finance.yahoo.comINVO Bioscience, Inc. (INVO) Stock Price, News, Quote & History - Yahoo FinanceMay 9, 2024 | Paradigm Press (Ad)Bitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…April 17, 2024 | msn.comMicro Cap Massively Bid Up Before Opening BellApril 17, 2024 | benzinga.comWhy Invo BioScience Stock Is Soaring TodayApril 17, 2024 | msn.comWhy Is Invo Bioscience (INVO) Stock Up 85% Today?April 17, 2024 | investorplace.comWhy Is Invo Bioscience (INVO) Stock Up 85% Today?April 17, 2024 | benzinga.comWhy INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving PremarketMay 9, 2024 | Paradigm Press (Ad)Bitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…April 17, 2024 | finance.yahoo.comAadi Bioscience, Inc. (AADI) Latest Stock News & Headlines - Yahoo FinanceApril 16, 2024 | msn.comINVO Stock Earnings: INVO Bioscience Reported Results for Q4 2023April 16, 2024 | finance.yahoo.comINVO Reports Fourth Quarter and Full Year 2023 Financial ResultsApril 4, 2024 | seekingalpha.comASMB Assembly Biosciences, Inc.February 22, 2024 | benzinga.comINVO Bioscience Stock (NASDAQ:INVO), Short Interest ReportFebruary 4, 2024 | morningstar.comINVO Bioscience Inc INVOJanuary 23, 2024 | marketwatch.comINVO BioScience Shares Up 5% as NAYA Agrees to Buy Florida BiotechnologiesJanuary 23, 2024 | finance.yahoo.comNAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)January 23, 2024 | finance.yahoo.comNAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)January 17, 2024 | finance.yahoo.comINVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board DirectorsDecember 23, 2023 | finance.yahoo.comINVO Bioscience, Inc. (INVO) Stock Historical Prices & Data - Yahoo FinanceDecember 11, 2023 | finance.yahoo.comNAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood JournalDecember 6, 2023 | msn.comNAYA, ONK team up to evaluate potential cancer therapy combinationsDecember 6, 2023 | finance.yahoo.comNAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell TherapiesNovember 28, 2023 | finance.yahoo.comINVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity RequirementNovember 14, 2023 | benzinga.comWhy INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving PremarketNovember 13, 2023 | finance.yahoo.comINVO Reports Record Third Quarter 2023 Financial ResultsNovember 13, 2023 | msn.comWhat's Going On With INVO BioScience Stock?See More Headlines Receive INVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today5/08/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:INVO CUSIPN/A CIK1417926 Webwww.invobioscience.com Phone(978) 878-9505FaxN/AEmployees25Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($12.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,030,000.00 Net Margins-459.42% Pretax Margin-265.05% Return on EquityN/A Return on Assets-88.87% Debt Debt-to-Equity Ratio2.94 Current Ratio0.15 Quick Ratio0.12 Sales & Book Value Annual Sales$3.02 million Price / Sales0.84 Cash FlowN/A Price / Cash FlowN/A Book Value($2.06) per share Price / Book-0.45Miscellaneous Outstanding Shares2,740,000Free Float2,647,000Market Cap$2.55 million OptionableNo Data Beta1.48 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Steven M. Shum (Age 53)CEO & Director Comp: $260kMr. Andrea Goren (Age 57)Chief Financial Officer Comp: $215kMr. Michael Jos. Campbell (Age 66)COO & VP of Business Development Comp: $220kMr. Bojan Mitrovic Ph.D.Director of Sales USMr. Robert Joseph Bowdring Jr. (Age 66)Treasurer & Secretary Ms. Terah KrigsvoldControllerMore ExecutivesKey CompetitorsDynatronicsNASDAQ:DYNTReShape LifesciencesNASDAQ:RSLSQuoin PharmaceuticalsNASDAQ:QNRXTenon MedicalNASDAQ:TNONProSomnusNASDAQ:OSAPView All Competitors INVO Stock Analysis - Frequently Asked Questions How have INVO shares performed in 2024? INVO Bioscience's stock was trading at $1.35 at the start of the year. Since then, INVO shares have decreased by 31.1% and is now trading at $0.93. View the best growth stocks for 2024 here. Are investors shorting INVO Bioscience? INVO Bioscience saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 12,100 shares, an increase of 10.0% from the March 15th total of 11,000 shares. Based on an average trading volume of 27,500 shares, the short-interest ratio is presently 0.4 days. Currently, 0.5% of the company's stock are sold short. View INVO Bioscience's Short Interest. When is INVO Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our INVO earnings forecast. How were INVO Bioscience's earnings last quarter? INVO Bioscience, Inc. (NASDAQ:INVO) posted its quarterly earnings data on Monday, November, 15th. The company reported ($4.80) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($4.00) by $0.80. The business earned $0.22 million during the quarter, compared to analysts' expectations of $0.25 million. During the same period in the prior year, the firm earned ($7.20) EPS. When did INVO Bioscience's stock split? INVO Bioscience's stock reverse split before market open on Thursday, July 27th 2023. The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of INVO Bioscience? Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:INVO) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.